Results 381 to 390 of about 4,008,604 (402)
Some of the next articles are maybe not open access.

Psoriasis: rationale for targeting interleukin-17

British Journal of Dermatology, 2012
The exact pathogenesis of plaque psoriasis remains to be fully determined, but it is thought to depend on environmental and genetic factors that stimulate dysregulated innate and adaptive immune responses in the skin. The cytokine interleukin (IL)-17A plays a key role in host defence against extracellular bacteria and fungi.
GIROLOMONI, Giampiero   +2 more
openaire   +3 more sources

Interleukin-17 in post-stroke neurodegeneration

Neuroscience & Biobehavioral Reviews, 2013
Stroke is a leading cause of physical disability with neurodegenerative sequelae such as dementia and depression causing significant excess morbidity. Stroke severity can be exacerbated by apoptotic cell death in ischemic tissue, of which inflammatory activity is a key determinant.
Krista L. Lanctôt   +6 more
openaire   +3 more sources

Interleukin-17: a mediator of inflammatory responses

Cellular and Molecular Life Sciences CMLS, 2004
Interleukin-17 (IL-17) is a prototype member of a new cytokine family with six species identified to date. IL-17 is secreted mainly by activated CD4(+) and CD8(+) T lymphocytes, while its receptor is distributed ubiquitously. IL-17 has been classified as a proinflammatory cytokine because of its ability to induce the expression of many mediators of ...
Achim Jörres   +2 more
openaire   +3 more sources

Interleukin-17 Antagonists in the Treatment of Psoriasis

Journal of Cutaneous Medicine and Surgery, 2015
Background Psoriasis is a chronic, immune-mediated inflammatory skin disorder of unknown etiology. Interleukin (IL)-17a, a key product of the recently identified Th17 cell subset, has been found to play a critical role in the immunopathogenesis of psoriasis.
Jensen Yeung   +1 more
openaire   +3 more sources

Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Nature Immunology, 2005
L. Harrington   +6 more
semanticscholar   +1 more source

To Be 17 Again — Anti–Interleukin-17 Treatment for Psoriasis

New England Journal of Medicine, 2012
Interleukin-17 is a cytokine that belongs to a family of six members (interleukins 17A through 17F), which bind a total of five receptors (interleukins 17RA through 17RE).1–3 Of these six interleukin-17 cytokines, interleukins 17A and 17F are very homologous and bind the same receptor complex (interleukins 17RA and 17RC).
openaire   +2 more sources

Interleukin-17 and fat: Timing is everything

Immunity
Interleukin-17 plays a major role in controlling adipose tissue homeostasis. In a recent study published in Nature, Douglas et al. demonstrate that time-of-day-dependent expression of interleukin-17 by tissue-resident innate lymphocytes in the adipose tissue drives circadian regulation of adipose tissue homeostasis and function.
Matthew C. Sinton   +3 more
openaire   +1 more source

Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells

Nature Immunology, 2007
Eva Acosta-Rodriguez   +7 more
semanticscholar   +1 more source

Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis

Progress in retinal and eye research, 2020
Zhenyu Zhong   +3 more
semanticscholar   +1 more source

Interleukin 17 Inhibitors

, 2021
M. Chima, M. Lebwohl
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy